| Summarized segment financial information |
| Three Months Ended March 31, 2020 |
| |
|
ADMA BioManufacturing |
|
Plasma Collection Centers |
|
Corporate |
|
Consolidated |
| |
|
|
|
|
|
|
|
|
| Revenues |
|
$ |
7,743,275 |
|
|
$ |
2,420,761 |
|
|
$ |
35,708 |
|
|
$ |
10,199,744 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of product revenue |
|
|
14,451,954 |
|
|
|
2,377,272 |
|
|
|
— |
|
|
|
16,829,226 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss from operations |
|
|
(12,476,144 |
) |
|
|
(457,155 |
) |
|
|
(3,836,487 |
) |
|
|
(16,769,786 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest and other expense, net |
|
|
(238,873 |
) |
|
|
— |
|
|
|
(2,236,571 |
) |
|
|
(2,475,444 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
(12,715,017 |
) |
|
|
(457,155 |
) |
|
|
(6,073,058 |
) |
|
|
(19,245,230 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital expenditures |
|
|
1,914,614 |
|
|
|
160,262 |
|
|
|
— |
|
|
|
2,074,876 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation and amortization expense |
|
|
674,973 |
|
|
|
111,289 |
|
|
|
2,576 |
|
|
|
788,838 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
|
|
104,645,897 |
|
|
|
5,376,807 |
|
|
|
100,501,123 |
|
|
|
210,523,827 |
|
| Three Months Ended March 31, 2019 |
| |
|
ADMA BioManufacturing |
|
Plasma Collection Centers |
|
Corporate |
|
Consolidated |
| |
|
|
|
|
|
|
|
|
| Revenues |
|
$ |
1,343,983 |
|
|
$ |
2,148,898 |
|
|
$ |
35,708 |
|
|
$ |
3,528,589 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of product revenue |
|
|
7,940,346 |
|
|
|
1,464,833 |
|
|
|
— |
|
|
|
9,405,179 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Loss) income from operations |
|
|
(10,620,807 |
) |
|
|
29,579 |
|
|
|
(2,617,188 |
) |
|
|
(13,208,416 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest and other (expense) income, net |
|
|
(169,613 |
) |
|
|
13,620 |
|
|
|
(1,268,472 |
) |
|
|
(1,424,465 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gain on transfer of plasma center assets |
|
|
— |
|
|
|
11,527,421 |
|
|
|
— |
|
|
|
11,527,421 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on extinguishment of debt |
|
|
— |
|
|
|
— |
|
|
|
(9,962,495 |
) |
|
|
(9,962,495 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net (loss) income |
|
|
(10,790,420 |
) |
|
|
11,570,620 |
|
|
|
(13,848,155 |
) |
|
|
(13,067,955 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital expenditures |
|
|
110,453 |
|
|
|
— |
|
|
|
— |
|
|
|
110,453 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation and amortization expense |
|
|
687,393 |
|
|
|
114,241 |
|
|
|
3,696 |
|
|
|
805,330 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
|
|
57,529,070 |
|
|
|
4,038,367 |
|
|
|
16,552,533 |
|
|
|
78,119,970 |
|
|